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Abstract: Background: Natural compounds with potential antioxidant properties have been used in the form of 
food supplements or extracts with the intent to prevent or treat various diseases. Many of these compounds can 
activate the cytoprotective Nrf2 pathway. Besides, some of them are known to impact the thyroid gland, often 
with potential side-effects, but in other instances, with potential utility in the treatment of thyroid disorders. 
Objective: In view of recent data regarding the multiple roles of Nrf2 in the thyroid, this review summarizes the 
current bibliography on natural compounds that can have an effect on thyroid gland physiology and pathophysi-
ology, and it discusses the potential implication of the Nrf2 system in the respective mechanisms.   
Method & Results: Literature searches for articles from 1950 to 2018 were performed in PubMed and Google 
Scholar using relevant keywords about phytochemicals, Nrf2 and thyroid. Natural substances were categorized 
into phenolic compounds, sulfur-containing compounds, quinones, terpenoids, or under the general category of 
plant extracts. For individual compounds in each category, respective data were summarized, as derived from in 
vitro (cell lines), preclinical (animal models) and clinical studies. The main emerging themes were as follows: 
phenolic compounds often showed potential to affect the production of thyroid hormones; sulfur-containing com-
pounds impacted the pathogenesis of goiter and the proliferation of thyroid cancer cells; while quinones and ter-
penoids modified Nrf2 signaling in thyroid cell lines. 
Conclusion: Natural compounds that modify the activity of the Nrf2 pathway should be evaluated carefully, not 
only for their potential to be used as therapeutic agents for thyroid disorders, but also for their thyroidal safety 
when used for the prevention and treatment of non-thyroidal diseases. 
Keywords: Personalized nutrition, phytochemical, flavonoid, Nrf2, thyroid, goiter, hyperthyroidism, hypothyroidism. 
1. INTRODUCTION 
 Food contains chemical compounds with potential ability to 
impact human health, either positively or negatively, by altering 
enzymatic reactions, cell signaling, and other biological processes 
[1]. Consumption of vegetables, fruits and whole grains can provide 
non-nutrient bioactive compounds, also known as phytochemicals, 
which can be involved in stimulation of the immune system, hor-
mone metabolism, scavenging of oxidants, regulation of genes im-
plicated in cell proliferation or apoptosis, antiviral and antibacterial 
processes, etc. Such compounds can potentially reduce the risk of 
diabetes, cardiovascular diseases, Alzheimer’s disease and other 
aging-related disorders [2-4]. Changing dietary habits in favor of 
plant-based foods may thus provide health benefits beyond the pro-
vision of basic nutrients. Adding fruits and vegetables rich in phy-
tochemicals into a diet is therefore promoted as a strategy for the 
prevention of chronic diseases. One plausible contributing mecha-
nism is that phytochemicals can provide protection against reactive 
oxygen species (ROS), thereby reducing the risk of various patho-
logical processes and diseases related to oxidative stress [5]. Ac-
cording to their mechanisms of action that confer protection against 
ROS, phytochemicals with antioxidant activity can be classified 
into (i) direct antioxidants, which are redox-active and have short 
half-lives; (ii) indirect antioxidants, which induce intracellular 
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pathways that can ultimately protect against oxidative stress; and 
(iii) bifunctional antioxidants, which have both properties [6]. 
However, the beneficial effect of natural compounds is often over-
emphasized, whereas data about potential toxicities associated with 
excess intake are in general scarce. Taking into account the classic 
principle of toxicology that “the dose makes the poison”, careful 
consideration should be given to the effects of the various phyto-
chemicals that are mainly consumed in the form of food supple-
ments, often without having undergone rigorous toxicological or 
clinical safety testing. Consequently, low levels of phytochemicals 
present in fruits and vegetables may offer health benefits, but these 
same compounds may be ineffective or even unsafe when con-
sumed at higher doses [7]. 
 The transcription factor Nrf2 (nuclear factor erythroid 2-related 
factor 2) is a major effector of antioxidant cellular responses and a 
target of phytochemicals, with protective effects against oxidative 
stress-related diseases [8, 9]. These phytochemicals are thus con-
sidered indirect antioxidants.  Under basal conditions, Nrf2 is se-
questered in the cytoplasm by the cysteine-rich protein Keap1 
(Kelch-like ECH-associated protein 1) that facilitates its ubiquitina-
tion and its subsequent degradation by the proteasome [10]. The 
sulfhydryl (-SH) groups of Keap1 cysteines act as “sensors” [11] 
that react with oxidative or electrophilic stressors or pharmacologi-
cal inducers of the Keap1/Nrf2 pathway to provoke conformational 
changes in Keap1 that render it incapable of facilitating the degra-
dation of Nrf2 molecules. Thus, de novo transcribed and translated 
Nrf2 can accumulate and, after various post-translational modifica-
tions, can enter the nucleus and induce the expression of its target 
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genes by binding to conserved ARE (Antioxidant Response Ele-
ment) sequences in their regulatory regions. Classic target genes of 
Nrf2 comprise cytoprotective and antioxidant enzymes such as 
heme oxygenase-1, NAD(P)H-quinone oxidoreductase-1, glutamate 
cysteine ligase, glutathione peroxidase, glutathione S-transferases, 
thioredoxin, thioredoxin reductase, and many others, including 
mediators of secondary antioxidant mechanisms, such as several 
proteasome subunits [12]. Pharmacological inducers of Nrf2 inter-
act with specific Keap1 cysteines and activate the Nrf2 pathway 
[13]. A very well characterized Nrf2 activator that can be found in 
its precursor form in natural products (cruciferous vegetables and 
especially broccoli) is the isothiocyanate sulforaphane [14-16]. 
Sulforaphane-rich broccoli sprouts extracts have been extensively 
used in series of preclinical and clinical studies, with the majority 
of them addressing the field of cancer chemoprevention, where 
sulforaphane has been proven effective against both genetic and 
chemical models of carcinogenesis in rodents [17]. As the use of 
sulforaphane in clinical trials has been expanding, it has been 
shown to enhance the detoxification of air pollutants [18], repress 
hepatic glucose production [19], and even ameliorate symptoms of 
autism spectrum disorder [20]. 
 Nrf2 is activated not only by sulforaphane but by many other 
phytochemicals. Broadly, natural compounds that can directly react 
with Keap1 cysteines or can induce low-level oxidative stress, may 
have the potential to induce the Nrf2 pathway, possibly along with 
other pathways [21]. Because very few studies have specifically 
focused on the potential impact of phytochemical-mediated Nrf2 
modulation on the thyroid gland and its pathologies, this mini-
review focuses on redox-active natural compounds that may affect 
the thyroid gland and may implicate the Nrf2 pathway as a mecha-
nism of action. 
1.1. Thyroid Gland Physiology and Hormone Synthesis 
 Normal anatomy and function of the thyroid gland, and normal 
concentration of thyroid hormones, are crucial prerequisites for 
optimal growth and development. Disorders of thyroid gland func-
tion, namely hyperthyroidism (hyperfunction) and hypothyroidism 
(hypofunction), as well as of thyroid anatomy, namely goiter (thy-
roid enlargement), are among the most common endocrine diseases. 
Though they can affect subjects of all ages, it is well documented 
that their prevalence increases with age [22-27]. Many substances 
and conditions are able to affect thyroid hormone biosynthesis and 
metabolism, including environmental and dietary factors, particu-
larly in areas characterized by nutritional iodine deficiency [28, 29]. 
 The thyroid gland synthesizes and secretes two main thyroid 
hormones, the highly active triiodothyronine (T3) and its much less 
active precursor, thyroxine (T4). For thyroid hormone synthesis to 
take place, it is necessary that the pituitary hormone thyrotropin 
(thyroid-stimulating hormone, TSH) binds to its receptor on the 
basolateral membrane of thyrocytes. The synthesis and secretion of 
TSH by the pituitary are stimulated by thyrotropin-releasing hor-
mone (TRH), which is secreted by the hypothalamus into the hypo-
thalamic-pituitary portal vein system. In turn, optimal serum levels 
of thyroid hormone are ensured principally due to the inhibitory 
effects of circulating T4 and of T3 on the secretion of TSH and 
TRH (the so-called negative feedback loop) [30]. 
 Another essential aspect for thyroid hormone synthesis is the 
particular organization of thyroid tissue and especially the polarity 
of thyroid follicular cells. The thyroid is comprised of follicles, 
spherical structures that represent the gland’s secretory and func-
tional units. Every thyroid follicle consists of grouped thyroid 
epithelial cells forming a spherical monolayer around a lumen filled 
with a viscous substance called colloid. Thyroid hormone synthesis 
takes place in the colloid, facing the apical plasma of thyrocytes. 
The opposite, basolateral side, is in contact with a network of blood 
capillaries, into which, the final synthesized thyroid hormones are 
secreted. 
 From the same capillaries, iodide (I-, the negatively charged 
anionic form of iodine) is taken up into the cells through the sodium 
(Na+)/iodide(I-) symporter (NIS), in order to be used for thyroid 
hormone synthesis [31]. Iodide is then transported towards the fol-
licular lumen (“iodine efflux”), in a process involving apical plasma 
membrane channels such as pendrin and anoctamin [32-34]. 
 In addition to iodide, the other main structural component re-
quired for thyroid hormone synthesis is thyroglobulin (Tg), a high 
molecular weight protein synthesized by the endoplasmic reticulum 
of thyrocytes. Iodide and Tg are brought together via the actions of 
thyroid peroxidase (TPO), an oxidoreductase enzyme localized at 
the apical plasma membrane that catalyzes a number of consecutive 
reactions. In the first step, iodide is oxidized by TPO in a reaction 
that requires hydrogen peroxide (H2O2), actively generated in thy-
rocytes by the enzyme, dual oxidase (DUOX, a NADPH oxidase) 
[35]. Oxidized iodide then binds to tyrosyl residues of Tg in a proc-
ess called Tg iodination or iodine organification; this process results 
in the formation of monoiodotyrosines (MIT) and diiodotyrosines 
(DIT) on the Tg molecule. In the next step, T3 and T4 are formed 
by the coupling of two iodotyrosines, one MIT and one DIT for T3, 
or two DIT for T4 [36]. When demand for thyroid hormone secre-
tion is low or absent, Tg is stored in the follicular lumen. Once 
needed, Tg enters the thyrocytes by micropinocytosis, whereby it is 
packed in vesicles. Inside the thyrocytes, these vesicles fuse with 
lysosomes, facilitating a proteolytic breakdown of Tg mediated by 
enzymes like cathepsin B, D and L. This is followed by degradation 
reactions catalyzed by lysosomal dipeptidase I, dipeptidyl-
peptidases I and II and N-acetyl-l-phenylalanyl-L-tyrosine hydro-
lase [37, 38]. Together, these reactions lead to the release of T3 and 
T4 from Tg. MIT and DIT undergo deiodination by the enzyme 
dehalogenase 1 (DEHAL1) that recycles iodide to be reused by 
thyrocytes, thus economizing on this trace element [39].  
1.2. Role of Nrf2 in the Thyroidal Antioxidant Response 
 In general, tissues that generate high amounts of free radicals 
(e.g., muscle) or have functions in detoxification (e.g., liver) are 
more susceptible to disorders caused by oxidative stress. As men-
tioned, in order to synthesize thyroid hormones, follicular cells 
require a constant physiological generation of H2O2 as the initiator 
of a series of oxidation reactions that result in the organification of 
iodide by the iodination of Tg. It is therefore not surprising that 
defense against oxidative stress is particularly vital for thyrocytes. 
Yet, in comparison to other tissues, relatively little is known about 
the role of proteostatic and antioxidant systems in the thyroid [24]. 
While a minimal amount of oxidative load is necessary in order for 
thyrocytes to proliferate and function normally [40, 41], intra-
thyroidal oxidative stress occurs during pathological conditions like 
goitrogenesis or iodine deficiency, and this in turn activates the 
thyroid’s antioxidant defenses [42-45]. 
 Recent work has shown that Nrf2 signaling has a central role in 
the antioxidant response of the thyroid gland [43]. Nrf2 regulates 
the expression levels of genes like thioredoxin reductase 1 and glu-
tathione peroxidase 2 [43], which are known to maintain homeosta-
sis in thyroid cells by ameliorating oxidative insults [46, 47]. In 
addition, Nrf2 protects the thyroid from oxidative damage induced 
by iodide overload [43]. Importantly, Nrf2 coordinates antioxidant 
defense in the thyroid gland with Tg production and iodination, and 
it can actually regulate the transcription of the gene encoding Tg by 
binding to two ARE sequences in a conserved enhancer [43]. 
 Regulation of Tg expression by Nrf2 makes biological and 
physiological sense, because both the Tg folding process and the 
iodination of Tg are mediated by oxidation reactions, as discussed 
above. For normal follicular function with optimal Tg economy, it 
is necessary to coordinate the regulation of antioxidant defense by 
Nrf2 with Tg production and iodination. Under normal conditions, 
Nrf2 prevents excessive Tg iodination by reducing ROS levels via a 
positive control of the expression of antioxidant genes. The role of 
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Nrf2 in protection from oxidative stress is even more important 
during iodide overload: as a response to high iodide intake, Nrf2 
activates a transcriptional program that limits ROS levels, prevent-
ing oxidative damage to biomolecules in follicular cells [43, 48, 
49]. Other genes involved in the specification, differentiation or 
function of thyroid follicular cells may also be impacted by Nrf2. 
Yet, in contrast to Tg, such regulation is apparently indirect and 
could result from the general redox status of the cell and/or from 
the crosstalk of Nrf2 with other pathways, as has been described 
also in other tissues [50-52]. Interestingly, when high doses of io-
dide were provided to mice lacking NIS, Tg iodination and thyroid 
hormone synthesis proceeded successfully to a certain degree [53]. 
In these conditions, a decrease in the mRNA levels of Nrf2 and of 
various antioxidant genes was also observed. Together, these data 
suggest that elevated TSH levels lead to a repression of Nrf2 signal-
ing in order to increase ROS levels, which in turn favors the oxida-
tive reactions necessary for Tg iodination and thyroid hormone 
synthesis [43, 54]. 
 Beyond its protective and physiological roles in normal thyroid, 
Nrf2 signaling has also been found to be activated in thyroid carci-
nomas, where it confers protection against oxidative stress and 
resistance to antineoplastic agents [55, 56]. 
1.3. Research aims and Strategy 
 The aim of this paper was to review the literature regarding 
natural substances with the potential to affect the physiology or 
pathophysiology of the thyroid gland, with a focus on those that are 
known to modulate the activity of Nrf2 as a mechanism of antioxi-
dant response. The ultimate goal was to assess the need for future 
studies on such compounds regarding their thyroidal effects and the 
estimation of doses that can be beneficial or at least safe for the 
thyroid gland. 
 The literature search and selection of articles for this mini-
review was conducted using Pubmed and Google Scholar for arti-
cles published in English from January 1950, through July, 2018. 
The following search terms were used: “natural compounds” or 
“natural substances” or “dietary flavonoids” or “phytochemicals” or 
“extracts” or “nutraceuticals” or “natural products”, in combination 
with “Nrf2” or “Nrf2 activation” or “Nrf2 inhibition” or “Nrf2 
modulation” or “Nrf2 pathway”, and “thyroid” or “antithyroid” or 
“goiter” or “goitre” or “goitrogenic”. To determine the relevance of 
publications, abstracts and/or titles were screened. Next, the full 
texts of selected studies were reviewed and all relevant references 
cited in these studies were also screened and included when perti-
nent. For compounds shown to have an effect on Nrf2, the literature 
was checked for any known activities in the thyroid, and vice versa. 
 In this manner, we identified, in particular, studies providing 
evidence regarding different effects of natural compounds on thy-
roid gland morphology and/or function. Regarding the involvement 
of Nrf2 as a mechanism of action of these compounds, we included 
only studies providing experimental evidence; papers with specula-
tive but experimentally unsupported mechanisms were excluded. 
2. PHENOLIC COMPOUNDS 
 Plants have the ability to synthesize secondary metabolites, 
including phenolic compounds [57]. In plants, these compounds 
play various roles during interactions with the environment, such as 
in the protection against ultraviolet radiation, in the attraction of 
seed-dispersing animals or pollinators, as well as in the defense 
against predators, parasites and pathogens [58]. Aside from provid-
ing plants with adaptive or survival strategies, phenolic compounds 
have commercial significance, because they are being used in the 
production of fibers, dyes, oils, flavoring agents and perfumes, and 
also as a source of  new antibiotics, natural drugs, herbicides and 
insecticides [59, 60]. This makes phenolic compounds a main re-
search focus for many scientists globally. Currently, around 8000 
phenolic compounds are known; they demonstrate wide structural 
diversity, ranging from simple phenolic acids to polyphenols (like 
flavonoids) to polymeric compounds. Flavonoids comprise the 
largest and most studied group among phenolic compounds; they 
are present in vegetables, fruits, spices, seeds, nuts, red wine and 
tea, and they are usually classified into isoflavonoids, flavanones, 
flavonols, flavanols (catechins), flavones, anthocyanidins and chal-
cones [61]. 
 Phenolic compounds originating from medicinal herbs and 
dietary plants have various biological activities, including modula-
tion of enzyme activities involved in oxidation and detoxification, 
as well as antiviral, antibacterial, anticancer, and anti-inflammatory 
effects[62]. 
2.1. Effects of Phenolic Compounds on Thyroid 
 Numerous conditions and chemical substances can alter thyroid 
function and affect the secretion of thyroid hormones and/or their 
availability to target tissues. Flavonoids, the largest class of pheno-
lic compounds, present in dietary plants and medical herbs, can 
interfere with thyroid hormone economy [29]. For example, in one 
of their first reported antithyroid effects, rats fed arachidoside and 
anacardioside pigments isolated from nuts developed goiter [63]. 
 Exposure to flavones apigenin, chrysin, vitexin and baicalein, 
present in parsley, cherries, thyme, olives, tea and broccoli, can 
inhibit TPO, the essential enzyme for thyroid hormone synthesis, 
which may lead to hypothyroidism (Table 1). As mentioned above, 
TPO catalyzes the oxidation reactions involving the iodide ion, the 
iodination of Tg, as well as the coupling of iodotyrosine residues on 
the Tg molecule. When TPO activity is inhibited by phenolic com-
pounds, reducing thyroid hormone synthesis, a compensatory in-
crease in TSH may be observed; this may lead to goiter, especially 
when these compounds are consumed in high quantities [28]. 
 The flavanols quercetin, fisetin, kaempferol, morin, myricetin 
and rutin, present in a wide range of food sources such as kale, 
onions, tomatoes, cherries, apples and red wine [5, 64], together 
with the flavanones naringenin and naringin, can also inhibit tyro-
sine iodination by TPO with varying potencies. TPO inactivation by 
kaempferol, quercetin, naringenin and fisetin is achieved by cova-
lent binding of reactive resorcinol radicals to catalytic amino acid 
radicals on TPO compound II, one of the intermediate oxidized 
states of the TPO enzyme formed during the coupling reactions 
[65]. Myricetin and naringin inhibit TPO non-competitively by 
different mechanisms, whereby inhibition of tyrosine iodination 
results from the binding of a substrate and inhibitor to different 
enzymatic forms or sites. They interact with TPO compound I (an-
other oxidized intermediate, formed during both the iodination and 
coupling reactions), as well as with compound II, but not with na-
tive TPO or with the enzymatic iodinating TPO species (another 
intermediate, resulting from the reaction of compound I with io-
dide). On the other hand, the isoflavone  biochanin A can serve as 
an alternative substrate for iodination; the competition between 
substrate and tyrosine for the enzymatic iodinating TPO species 
initially leads to incomplete blockade of tyrosine iodination, be-
cause the affinity for biochanin A is higher [65, 66]. 
 The soybean-derived isoflavones genistein and daidzein, in 
concentrations similar to those present in the serum of subjects 
consuming soy derivatives, are able to inactivate TPO and to inhibit 
iodine organification in vitro [77]. Isoflavones can also interfere 
with thyroid hormone transport proteins and with 5´-deiodinase 
type I (5DI) in peripheral tissues, leading to changes in thyroid 
hormone activity at cellular level. The enzyme 5DI catalyzes the 
conversion of T4 to T3, the biologically active hormone [91]. In 
orchidectomized middle-age rats, total serum T4 and T3 levels 
decreased after treatment with daidzein and genistein [74]. Besides 
TPO activity, discussed above, deiodination via 5DI can also be 
affected by baicalein, quercetin, kaempferol and rutin [69]. 
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Table 1. Phenolic compounds and their effects on thyroid. 
Compound Model system Impact on thyroid function and/or morphology 
Apigenin 
WHO, ARO, NPA cells [66]; FTC-133 cells [67]; por-
cine thyroid slices, R [68] 
AC [66]; ↓I retention [67]; TPOI and iodine organificationI in follicles 
[68]  
Baicalein porcine TPO  [65]; R [69]; ATC cells [70] tyrosine iodinationI by TPO [65]; 5D1I [69]; AC [70] 
Biochanin A WHO, ARO, NPA cells [66]; R[69]; porcine TPO  [65] AC [66]; 5D1I [69]; TPOI [65] 
Chrysin WHO, ARO, NPA cells [66] AC [66]  
Cinnamaldehyde, 
Cinnamon 
R [71] ↓T3, modulate tissue-specific expression of TH receptor [71] 
Curcumin R [72]; SW1736, 8505C cells  [73] thyro-protective [72]; AC [73]  
Daidzein M [69]; R [74]  5D1I [69]; ↑TSH, ↓T4, ↓T3, G [74] 
Ferulic acid MTC cells [75] AC [75] 
Fisetin R [69]; FTC-133 cells [67]; porcine TPO [28] ↑5D1 [69]; ↓IU [67]; ↓TPO [28] 
Genistein 
TPC-1, FTC-133, FRO, WHO, ARO, NPA cells [66, 
76]; porcine TPO [65]; human goiter Tg, TPO [77] ; 
8505C cells [73]; R [74] 
AC [66, 76]; TPOI [65]; TPOI ,↓T4 [77]; ↓colony formation [73]; 
↑TSH, ↓T4, ↓T3, G [74] 
Glucosylorientin and 
glucosylvitexin 
P [68] TPOI, AT [68] 
Hesperetin R [78] moderate colloid depletion, ↑Tg [78] 
Hesperidin R [68] AT [68] 
Kaempferol 
WRO, ARO, NPA cells [66]; FTC-133 cells [67]; por-
cine TPO [65] 
AC [66]; ↓iodide retention; AT [67]; TPOI [65] 
Luteolin 
WRO, ARO, NPA cells [66]; FTC-133 cells [67]; por-
cine thyroid slices, R [68] 
AC [66]; ↓I retention [67]; TPOI, iodine organificationI in follicles 
[68] 
Mearnsitrin porcine TPO [65]; human toxic diffuse goiter tissue  [79] AT, TPOI [65]; induce hypoT and G [79] 
Morin porcine TPO  [65]; R  [69] TPOI [65]; 5D1I [69] 
Myricetin 
FTC-133 cells [67]; SNU-80 HATC cells [80]; R [69]; 
porcine TPO [65] 
↑IU, AC [67]; AC [80]; 5D1I [69]; TPOI [65] 
Myricitrin 
TPO isolated from human toxic diffuse 
goiter tissue [79] 
TPOI  [79] 
Naringenin porcine TPO [65]; FTC-133 cells [67]; R [78] 
tyrosine iodinationI by TPO [65]; ↓IU [67]; moderate colloid deple-
tion, ↑TSH, ↑Tg [78] 
Phenolic acids R [68] TPOI [68]  
Phloretin porcine TPO [29, 81] AT [29, 81] 
Phloroglucinol R [29] TPOI [29] 
Puerarin R [82] ↑thyroid gland weight [82] 
Quercetin 
FTC-133 cells [67]; R [69]; R [83]; porcine TPO [65]; 
FRTL-5 cells [84]; TPC-1, FTC-133, NPA, FRO, ARO 
cells [76]; R  [72] 
↓IU [67]; ↓T3 serum levels, 5D1I [69]; ↓TSH receptor, TPO and TG 
genes expression [83]; TPOI [65]; cell growth and NIS gene expres-
sionI [84]; AC [76]; thyro-protective [72] 
Resorcinol R  [29] TPOI [29] 
Resveratrol 
TPC-1, FTC-133, NPA, FRO, ARO cells [76]; FRTL-5 
cells [85]; PTC, FTC cell lines [86] 
AC [76]; ↑iodide influx, ↑NIS [85]; AC [86]  
(Table 1) Contd.... 
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Compound Model system Impact on thyroid function and/or morphology 
Rottlerin FTC cells [87] AC [87] 
Rutin porcine TPO [69] ↓TPO [69] 
Silymarin M [88] ↑5D1, ↑T4, ↑T3 after carbon tetrachloride administration [88] 
Vitexin R [68] TPOI, G, AT [68]  
Xanthohumol FRTL-5 cells [89]; HEK293 cells [90] ↑IU [89]; iodothyronine deiodinasesI [90] 
Effects listed in the right column and separated by semicolons have been derived from corresponding models shown in the middle column and separated by 
respective semicolons. 
5DI, type I 5´-deiodinase; AC, anticancer; R, rat; ↑, increase; ↓, decrease; P, porcine; I, inhibit; G, goitrogenic; AT, antithyroid; HypoT, hypothyroidism; IU, 
iodide uptake; TH, thyroid hormone; M, mice; ATC, anaplastic thyroid carcinoma; FTC, follicular thyroid carcinoma; PTC, papillary thyroid carcinoma; MTC, 
medullary thyroid carcinoma. 
 
 Hesperetin and naringenin are flavones from citrus fruits. Being 
potent antioxidants, they can improve the cardiovascular and meta-
bolic status; however, they may also interfere with thyroid hormone 
economy. When administered to aged rats at high doses, serum 
TSH increased in response to naringenin treatment, while T4 re-
mained unaltered in response to either naringenin or hesperetin 
treatment [78]. 
 Quercetin is a flavonoid that is naturally abundant in a broad 
range of vegetables and fruits; it is also available as a dietary sup-
plement with purported anti-inflammatory, antioxidant and antipro-
liferative properties. However, quercetin might carry a potential 
toxicity risk when consumed in excessive quantities, and it can 
interfere with thyroid function by inhibiting thyroid cell growth and 
iodide uptake. Iodide uptake inhibition is the result of down-
regulation of NIS gene expression [84]. Quercetin may also down-
regulate the expression of Tg and of the TSH receptor [83].  
 Besides inducing changes in thyroid function upon excessive 
intake, flavonoids can also have a crucial role in carcinogenesis-
associated events, including invasion, kinesis modulation, apoptosis 
induction and cell cycle regulation. Cell culture studies have shown 
that flavonoids have an inhibitory effect on the proliferation of 
thyroid cancer cells by interfering with key enzymes in cell signal-
ing and cell proliferation pathways, such as protein tyrosine kinase 
(PTK), protein kinase C (PKC), and DNA topoisomerases I and II 
[92, 93]. 
 Apigenin, biochanin A, chrysin, genistein, luteolin and 
kaempferol can effectively inhibit the proliferation of cell lines 
derived from follicular, papillary and anaplastic thyroid carcinomas 
[66]. Besides inhibiting cancer initiation and progression, resvera-
trol, quercetin and genistein can also induce redifferentiation of 
thyroid cancer cells [76]. Many flavonoids inhibit thyroid cancer 
growth, but they also inhibit iodine uptake. Iodine uptake is not 
only an important step in thyroid hormone synthesis, but also a 
crucial exploitable mechanism for the treatment of differentiated 
(papillary and follicular) thyroid carcinoma with radioactive iodine. 
In this regard, among flavonoids thus far tested, myricetin would be 
an interesting modality for the treatment of thyroid carcinoma due 
to its capacity to increase iodide uptake and retention [67]. 
2.3. Modulation of Nrf2 Activity by Phenolic Compounds  
 Using in vitro and in vivo approaches, several studies have 
demonstrated the potential role of Nrf2 activation by phenolic com-
pounds in the protection against oxidative stress, inflammation, 
cancer, and various other specific cellular toxicities, such as he-
patic, cardiac and neuronal toxicities (Table 2). Of note, these stud-
ies did not focus specifically on thyroid tissue or thyroid cell lines, 
and therefore further research is warranted to evaluate if the de-
scribed effects on the Nrf2 pathway are also applicable to the thy-
roid gland.  
 
 Many phenolic compounds, such as epigallocatechin-3-gallate, 
curcumin and catechins exert an antioxidative and anti-
inflammatory effect through antioxidant enzymes that are regulated 
by Nrf2 [159-161]. Curcumin, found in turmeric, stimulates Nrf2 
transcriptional activity in a time- and dose-dependent manner, re-
sulting in the induction of heme oxygenase 1 (HO-1) protein ex-
pression [107]. Luteolin and apigenin protect against oxidative 
stress through up-regulation of HO-1 and of glutamate cysteine 
ligase catalytic subunit via Nrf2 pathway induction [96]. The 
isoflavone biochanin A from cabbage, red clover and alfalfa 
showed antioxidative [162] and hepatoprotective effects by induc-
ing Nrf2 nuclear translocation and up-regulation of HO-1 expres-
sion, resulting in the inhibition of oxidative liver injury induced by 
lipopolysaccharide in combination with D-galactosamine N 
(LPS/GalN) [101]. In a study with aged rats, treatment with hes-
peridin elevated the myocardial antioxidative status by lowering 
lipid peroxidation and protein oxidation, increasing glutathione 
(GSH) levels and inducing the Nrf2 pathway, which led to higher 
expression levels of antioxidant enzymes [122]. Morin exerts cyto-
protective and genoprotective effects against oxidative stress. 
Morin treatment prior to H2O2 exposure significantly prevented the 
generation of ROS, increased cell viability and prevented DNA 
damage by up-regulating Nrf2-dependent HO-1 expression through 
extracellular signal-regulated kinases (ERK) in C2C12 myoblasts 
[133]. In the case of myricetin, production of pro-inflammatory 
mediators through the suppression of signal transducer and activa-
tor of transcription 1 (STAT1) and Nuclear factor kappa-light-
chain-enhancer of B cells (NF-kB) activation was inhibited by in-
duction of Nrf2-mediated HO-1 expression in LPS-stimulated 
macrophages [134]. 
 Interestingly, besides activating the Nrf2 pathway, some pheno-
lic compounds can also inhibit the same pathway, with the potential 
therapeutic application against chemotherapy resistance. Apigenin 
significantly lowered Nrf2 expression at the protein and mRNA 
levels, at least partially through down-regulation of the PI3K/Akt 
pathway in a human papillomavirus-related endocervical adenocar-
cinoma cell line. Inhibition of Nrf2 by apigenin increased the intra-
cellular concentration of doxorubicin and led to resensitization of 
these cells that were formerly resistant to the drug [163]. Reduction 
of protein and mRNA levels of Nrf2 after luteolin treatment sensi-
tized A549 lung cancer cells to doxorubicin, potentially due to de-
pletion of reduced glutathione resulting from down-regulation of 
ARE-driven genes [131]. Luteolin has also been shown to repress 
Nrf2 signaling in mouse livers and in A549 xenografts [132]. 
Hence, there is substantial mechanistic evidence that apigenin and 
luteolin can downregulate Nrf2 signaling by affecting Nrf2 mRNA 
stability [131] or modulating pathways such as PI3K [98]. This 
apparent discrepancy in the effects of apigenin and luteolin on the 
activity of the Nrf2 pathway might be due to the different models 
used in the various studies, or/and to some unappreciated toxic 
effect of these compounds on some cell lines, which could lead to 
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Table 2. Phenolic compounds and their effects involving Nrf2. 
 Compound Model System Impact on Nrf2 and Effect 
2´,3´-Dihydroxy-4´,6´-
dimethoxychalcone 
PC12 cells [94] Nrf2-ARE PtWA, NP [94] 
4,2´,5´-Trihydroxy-4´-
methoxychalcone 
peritoneal macrophages  [95] induces the expression of HO-1 via Nrf2 PtW, AI [95] 
Apigenin 
HepG2 [96]; R primary 
hepatocytes [97]; BEL-7402 [98] 
PI3K/Nrf2/AREA, AI [96]; HO-1, GCLC, GCLM gene transcription via 
ERK2/Nrf2/ARE PtW, AO [97]; downregulation of Nrf2 mRNA and protein 
[98] 
Aurone Hepa1c1c7 cells  [99] Nrf2/ARE PtWA, ChP [99] 
Baicalein PC12 cells [100] Keap1/Nrf2/HO-1 PtWA, NP [100] 
Biochanin A M [101] Nrf2 PtWA, CyP [101] 
Brazilin HEI-OC1 cells  [102] ↑nuclear translocation of Nrf2, CyP [102] 
Cajaninstilbene acid HepG2 cells [103] Nrf2I by siRNA, AO [103] 
Chrysin 
R primary 
hepatocytes [97] 
HO-1, GCLC, GCLM gene transcription 
via ERK2/Nrf2/ARE PtW, AO [97] 
Cinnamaldehyde, 
Cinnamon 
HepG2, HCT116, HT29  [104] Nrf2-regulated ARE-mediated gene expressionA, ChP [104] 
Curcumin 
vascular smooth muscle cells [105]; 
M [106]; Renal epithelial cells [107] 
Nrf2 overexpression, ADb [105]; Nrf2-mediated phase II AO enzymesA, AO, AI 
[106]; ↑Nrf2 expression, ChP [107] 
Daidzein endothelial cells [108] Nrf2-Keap1 PtWA, CyP, AC [108] 
Danshensu PC12 cells [109] ↑nuclear translocation of Nrf2, NP [109] 
Dehydroglyasperin C mouse hippocampal HT22 cells [110] Nrf2-Keap1 PtWA, NP [110] 
Eriodictyol 
human primary endothelial cells 
[111]; PC12 cells [112] 
HO-1through ERK/Nrf2/ARE PtW [111]; Nrf2/ARE PtWA, AO [112] 
Eriodictyol-7-O-glucoside HRMC cells  [113] ↑Nrf2 protein level, CyP [113] 
Eupatilin 
feline ileal smooth 
muscle cells [114] 
HO-1 induction by Nrf2 PtW [114] 
Ferulic acid 
human umbilical vein endothelial 
cells [115] 
induces Nrf2A, CP [115] 
Fisetin 
human umbilical vein endothelial 
cells [116] 
AO [116] 
Gastrodin rat hippocampal neurons [117] ↑Nrf2 expression-AO, NP [117] 
Genistein 
PC12 cells [118]; R [119]; EA.hy926 
[120] 
Nrf2/HO-1 PtWA, NP [118]; Nrf2 mediated phase II AO enzymesA, AO, HP 
[119]; Nrf2A, CyP, AO [120] 
Hesperetin ARPE-19 cells [121] H2O2 protection via Keap1-Nrf2/HO-1 PtW, AO [121] 
Hesperidin R [122] Nrf2 protein level, CarP [122] 
Icariside II HepG2 cells [123] Nrf2-related antioxidant proteins HO-1 and GST, AO [123] 
Isoorientin 
HepG2 cells  [124] 
 
induces Nrf2 PtW-driven AO response [124] 
Kaempferol 
HepG2-C8 [125]; HEI-OC1 [126]; 
RBL-2H3 [127] 
↑mRNA and protein expression of Nrf2-regulated genes, HP [125]; via JNK PtW 
and Nrf2- translocationA, CyP [126]; Nrf2 mediated HO-1 induction, AAl 
[127] 
(Table 2) Contd.... 
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 Compound Model System Impact on Nrf2 and Effect 
Lithospermic acid B pancreatic β-cells [128] Nrf2/HO-1-ADb, CyP [128] 
Lucidone Ava5 cells [129]; HaCaT cells [130] 
↑Nrf2-mediated HO-1 expression- anti-HCV[129]; HO-1/Nrf2 AO genes, AO, 
AI [130] 
Luteolin 
HepG2 [96]; R primary 
hepatocytes [97]; A549 [131]; mouse 
liver and A549 xenografts [132] 
PI3K/Nrf2/AREA, AI [96]; HO-1, GCLC, GCLM gene transcription via 
ERK2/Nrf2/ARE PtW, AO [97]; repression of Nrf2 mRNA [131]; repression of 
Nqo1 [132] 
Morin C2C12 myoblasts [133] Nrf2-dependent HO-1 expression, CyP [133] 
Myricetin RAW264.7 macrophages [134] Nrf2-mediated HO-1 induction, AI [134] 
Myricitrin H9c2 cardiomyocytes [135] Akt-dependent Nrf2 signaling PtWA, CyP [135] 
Naringenin H9c2 [136]; SH-SY5Y [137]; R [138] 
Nrf2 target genes, CP [136]; Nrf2/ARE PtWA, NP [137]; nuclear translocation 
of Nrf2, AO, AI [138] 
Okanin RAW264.7 macrophages [139] ↑Nrf2-mediated HO-1 expression, AI [139] 
Phenolic acids R [140] ↑Nrf2 protein expression, AO [140] 
Phloretin R hepatocytes [141] HO-1 and GCL through ERK2/Nrf2 PtW [141] 
Phloroglucinol SH-SY5Y cells [142] ↑Nrf2A, NP [142] 
Piceatannol 
MCF10A cells [143]; HT22 neuronal 
cells [144] 
HO-1 through Nrf2A, CyP [143]; NP [144] 
Protocatechuic acid murine macrophages  [145] Nrf2Aby JNK MAP kinase, AO [145] 
Puerarin Hepa1c1c7, HepG2  [146] HO-1 induction via the PI3K-Nrf2 PtW, AO, CyP [146] 
Quercetin HepG2 cells [147] Nrf2/ARE-mediated NQO1 expressionA, ChP [147] 
Resveratrol R [148] Nrf2–Keap1A-AI, NephP [148] 
Rottlerin HT29 cells [149] nuclear translocation of Nrf2, AO [149] 
Rutin R [150] ↑Nrf2 level-AI, AO [150]  
Sappanchalcone 
human pulp and periodontal ligament 
cells [151] 
Nrf2 PtWA-AI, CyP [151] 
Silymarin R, A549  [152] Nrf2- AO, AI [152] 
Taxifolin M, mast cells [153] ↑Nrf2 PtW-ChP, AI, AO, AC [153] 
Vitexin Neuro-2a cells [154] ↑Nrf2 level -AO, NP [154] 
Xanthohumol 
PC12 [155]; M [156]; HepG2, THLE-
2 [157]; BV2 cells [158] 
Nrf2 enzymesA, NP [155]; Nrf2 PtW via AMPKA and GSK3βI, AI [156]; 
Nrf2A, ChP [157]; Nrf2-ARE PtWA, AI [158] 
Effects listed in the right column and separated by semicolons have been derived from corresponding models shown in the middle column and separated by 
respective semicolons. 
M, mice; R, rat; , up-regulate; AO, antioxidative; AI, anti-inflammatory; PtW, pathway; A, activate; I, inhibit; CarP, cardioprotective; ChP, chemoprotective; 
HO-1, heme oxygenase 1; PKC-­‐δ, protein kinase C delta; ↑, increase; ↓, decrease; P, porcine; NP, neuroprotective; CyP, cytoprotective; ERK, extracellular 
signal-regulated kinase; NQO1, NAD(P)H quinone dehydrogenase 1; γGCS, gamma glutamyl cysteine synthetase; AC, anticancer; NF-Kb, nuclear fac-
tor kappa-light-chain-enhancer of activated B cells; GST, glutathione S-transferase; PI3K, phosphoinositide-3-kinase; AAl, anti-allergic; ADb, antidiabetic; 
JNK, c-Jun N-terminal kinase; MAP, microtubule-associated protein; GCL, glutamate cysteine ligase; HCV, hepatitis C virus; GCLC, GCL catalytic subunit; 
GCLM, GCL modifier subunit. 
 
secondary induction of the Nrf2 pathway. In that regard, it should 
be noted that the studies showing inhibition of the Nrf2 pathway are 
better supported by mechanistic analyses [98, 131], whereas more 
research is warranted to determine how it may be mechanistically 
possible for these compounds to also activate the Nrf2 pathway in 
certain settings. 
 
3. EFFECTS OF SULFUR-CONTAINING COMPOUNDS ON 
THE NRF2 PATHWAY AND ON THE THYROID 
 Isothiocyanates including allyl isothiocyanate (AITC), benzyl 
isothiocyanate (BITC), phenethyl isothiocyanate (PEITC) and sul-
foraphane, from cruciferous vegetables such as brussels sprouts, 
broccoli, cauliflower, cabbage and watercress, are strong chemo- 
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protective and anticancer agents [164]. Isothiocyanates are present 
in these vegetables as inactive precursors (glucosinolates), from 
which they are released when plant cells are damaged. Glucosi-
nolates are converted into isothiocyanates by the enzyme my-
rosinase, which is also present in the human gut microflora. Expo-
sure to antibiotics that alter the microflora can largely reduce the 
conversion of glucosinolates into isothiocyanates [165]. The 
bioavailability of isothiocyanates is also affected by diurnal varia-
tions, with higher conversion of glucosinolates to dithiocarbamates 
during the day, and higher conversion of isothiocyanates to dithio-
carbamates during night [166]. Isothiocyanates  induce cytoprotec-
tive proteins via the Nrf2/Keap1/ARE pathway, thus conferring 
protection against oxidants and electrophiles and thereby potentially 
exerting chemopreventive and/or therapeutic actions against a wide 
range of diseases [167]. 
 Sulforaphane and AITC treatment in hepatocellular carcinoma 
HepG2 cells potently induced HO-1 protein expression via Nrf2 
pathway induction (Table 3). PEITC can also induce the protein 
expression levels of Nrf2 and HO-1 by stimulating ARE-mediated 
transcription in Hela cells [168, 169]. 
Diallyl sulfides from onion, chive and garlic, such as diallyl sul-
fide (DAS), diallyl disulfide (DADS), and diallyl trisulfide (DATS), 
can also act as potential chemoprotective agents. Diallyl sulfides 
can affect the expression of Nrf2, HO-1, NAD(P)H quinone dehy-
drogenase 1 (NQO1) and other proteins encoded by ARE-regulated 
genes. For example, DAS induces HO-1 through the production of 
ROS, and this induction is mediated by Nrf2 and mitogen-activated 
protein kinases (MAPK), while DADS and DATS induce glu-
tathione reductase, glutathione S-transferases, ferritin and NQO1 in 
cultured cells and in animals [173, 174, 183-185]. 
 Sulfur-containing compounds can modulate thyroid function 
and might be efficacious in inhibiting thyroid cancer progression. 
Through an ROS-dependent pathway, sulforaphane inhibits thyroid 
cancer cell proliferation, invasion and migration, and it induces cell 
cycle arrest without significant toxicities such as liver injury, which 
makes it a potentially effective and safe modality for cancer treat-
ment [182]. In many animal models, DAS inhibits chemically-
induced carcinogenesis. For example, treatment of the anaplastic 
thyroid cancer cell line ARO with DAS inhibited proliferation by 
increasing in a dose-dependent manner, the accumulation of sub-G1 
DNA and the associated accumulation of cells in the G2/M phase 
via mitochondrial signaling pathways [175]. 
 BITC, which has been extensively used as a chemopreventive 
agent, has been shown to decrease total T4 and T3 levels in rats 
after two weeks of daily treatment at doses known to have anticar-
cinogenic effects [172]. 
In another study, rats were fed with a combination of goitrin, a 
sulfur-containing oxazolidine, thiocyanate and AITC, in concentra-
tions comparable to those present in the daily amount of cabbage 
that these rats can consume, and this treatment resulted in increased 
thyroid size. This effect could not be reproduced by administering 
individually any of these compounds, meaning that only their com-
Table 3. Modulation of Nrf2 pathway and thyroid function by sulfur-containing compounds. 
Model system 
Compound 
Nrf2 Thyroid 
Impact on Nrf2 
Impact on thyroid 
function/morphology 
6-Methylthiohexyl isothiocy-
anate 
HepG2 cells - 
modulates ARE-mediated NQO1 expression by 
stabilizing Nrf2, CyP [170]  
- 
Allyl ITC(AITC) HepG2 R 
induces Nrf2 protein expression, ARE-reporter 
gene and HO-1, ChP [168]  
↑T size, AT [171]  
Benzyl ITC (BITC)  R  ↓T3 and T4 [172]  
Diallyl disulfide (DADS) 
Diallyl trisulfide (DATS) 
HepG2 cells - Nrf2 protein accumulation and AREA, ChP [173] - 
Diallyl sulfide (DAS) HepG2 cells ATC cells 
Nrf2/MAPK-mediated induction of HO-1, ChP 
[174] 
AC [175] 
Phenethyl ITC (PEITC) HeLa cells - 
ARE-mediated phase II DME gene expressionA 
via JNK1- and Nrf2-dependent PtW, ChP [169] 
- 
S-allylcysteine (SAC) R R 
Nrf2-mediated of antioxidant and phase II 
enzymes-HP, AO [176] 
↑T3 and T4 [177]  
Sulforaphane 
R; mouse peritoneal 
macrophages; M and 
H9c2 cells; HK2 
renal tubular epithe-
lial cells; HepG2 
FTC133, 
8305C, BCPAP 
and K1 cells 
↑Nrf2 and HO-1 expression, NP [178]; Nrf2A, AI 
[179]; Nrf2, CarP [180]; Nrf2-dependent phase 
2 enzymeA, NephP [181]; induces Nrf2 protein 
expression, ARE-reporter gene and HO-1, ChP 
[168] 
AC [182]  
Thiocyanates 
Goitrin 
- R - ↑T size, AT [171] 
Effects listed in the fourth and fifth column and separated by semicolons have been derived from the corresponding models shown in the second and third 
columns, respectively, and separated by respective semicolons. 
R, rat; T, thyroid; AT, antithyroid; DME, drug-metabolizing enzyme; JNK1, c-Jun N-terminal kinases; PtW, pathway; ChP, chemoprotective; HO-1, heme 
oxygenase 1; ↑, increase; NP, neuroprotective; A, activate; AI, anti-inflammatory; , up-regulate; CarP, cardioprotective; NephP, nephroprotective; AC, anti-
cancer; MAPK, mitogen-activated protein kinase; HP, hepatoprotective; AO, antioxidative; NQO1, NAD(P)H quinone dehydrogenase 1; CyP, cytoprotective. 
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bination, as found in cabbage, can lead to increased thyroid size 
[186]. Of note, in a recent randomized clinical trial, we showed that 
daily administration of a sulforaphane-rich broccoli sprout extract 
to healthy volunteers did not have any detrimental effect on thyroid 
function or the thyroid autoimmunity status [187]. 
 The most abundant sulfur-containing compound from garlic, S-
allylcysteine (SAC), has a potential beneficial effect in diabetes. In 
streptozotocin-induced diabetic rats, TSH and thyroid hormone 
levels decreased, along with circulating catalase (CAT), GSH, glu-
tathione peroxidase (GPx), superoxide dismutase (SOD) and insulin 
levels. Treatment with SAC reversed these effects and could be 
used to restore antioxidant capacity, reduce lipid peroxidation and 
preserve thyroid function in diabetic subjects [177]. 
4. QUINONES AND TERPENOIDS 
 Quinones and terpenoids, including mono-, di-, tri-, and ses-
quiterpenoids, are organic compounds with high diversity in struc-
ture and bioactivity (Table 4). Even though many reports demon-
strate that these compounds can activate the Nrf2 pathway, their 
potential effects on thyroid physiology and disease are rarely exam-
ined. In view of the highly variable chemical structures and biologi-
cal activities of quinones and terpenoids, further research of their 
actions on the thyroid could give interesting insights into potential 
beneficial and/or detrimental effects. 
5. PLANT EXTRACTS AND THYROID 
 Extracts from plants and medical herbs, even though they may 
contain several compounds in variable and unstandardized concen-
trations, comprise a rich source of candidate drugs that may have 
potential effects on thyroid gland function (Table 5). 
 Medical herbs such as Lycopus americanus, Lycopus eu-
ropaeus, Lycopus virginicus arious, Lithospermum officinale and 
Lithospermum ruderale show promising potential for the treatment  
of hyperthyroidism, while Plectranthus barbatus, Withania somnif-
era, Centella asiatica and Commiphora mukul might be useful to 
treat hypothyroidism. Interestingly, withaferin A, which is con-
tained in Withania somnifera, has recently been shown to be a po-
tent inducer of the Nrf2 pathway [215]. Treatment for hyperthyroid-
ism and hypothyroidism with herb extracts can have variable effects 
and may be sufficient for treating symptoms in some cases, but at 
the present state of knowledge, it should not be used in the place of 
established conventional treatment, especially for serious thyroid 
disorders [216]. 
 Boiled extracts of cassava, bamboo shoot, cauliflower and cab-
bage can inhibit TPO activity [217]. Kalanchoe brasiliensis aqueous 
extract can also inhibit TPO, and experiments with this extract 
showed that chronic consumption combined with low iodine intake 
can cause hypothyroidism and goiter [218]. In mice, leaf extracts of 
Aegle marmelos, Bacopa monnieri and Aloe vera can alter thyroid 
hormone concentrations. Aloe vera and Aegle marmelos decreased 
T3 concentration and could thus provide a beneficial effect in the 
treatment of hyperthyroidism, whereas Bacopa monnieri increased 
T4 concentration and could be useful for the treatment of hypothy-
roidism [219].  
 Rats treated with green and black tea extract rich in catechins 
showed decreased T3 and T4 serum levels as well as decreased 5DI 
and TPO activity, while Na+/K+-ATPase activity was increased 
along with TSH levels. Treatment also led to hypertrophy and/or 
hyperplasia of thyroid follicles, with reduced colloid content [220]. 
 Plant extracts can also provide potential new approaches in 
thyroid cancer treatment. Aglaia coriacea, Aglaia gracilis, Aglaia 
elaeagnoidea, Aglaia edulis, Aglaia odorata, and Stemona tuberosa 
extracts inhibited the proliferation of medullary thyroid carcinoma 
cell lines. Aglaia basiphylla, Aglaia basiphylla, Aglaia tenuicaulis 
and Stemona collinsae extracts had antiproliferative effects, 
whereas apoptotic effects were seen in cells treated with Stemona 
tuberosa extract [221]. 
6. OTHER COMPOUNDS MODULATING NRF2 PATHWAY 
AND THYROID FUNCTION 
 Apart from the aforementioned categories of phytochemicals, 
other naturally occurring compounds can also activate the Nrf2 
pathway and affect thyroid function; these are listed in Table 6. 
CONCLUSION 
 The use of phytochemicals from edible plants may provide a 
sustainable and effective solution for the treatment and prevention 
of diseases, with potential clinical utility both in underdeveloped 
countries that still do not have access to expensive medications, as 
well as in developed countries challenged by increasing healthcare 
costs and/or endorsing complementary medicine. Food-derived 
phytochemicals with cytoprotective and antioxidant properties have 
already been tested for potential use in a wide range of diseases, 
including cardiac and psychiatric disorders, diabetes, viral, micro-
bial and parasitic infections, inflammation and cancer. However, 
little is known about the impact of phytochemicals on thyroid func-
tion and the potential underlying modulation of the Nrf2 pathway, 
an important mediator of antioxidant, cytoprotective and other 
effects in cells. We and others have recently shown the importance 
of the Nrf2 pathway in the thyroid gland; Nrf2 not only coordinates 
the antioxidant response under basal and iodide excess conditions, 
but it also regulates the transcription of the Tg gene itself, and it 
further affects the iodination of Tg under various conditions [43]. 
Thus, the Nrf2 pathway can potentially integrate the protection of 
thyroid cells from excessive ROS production with the regulation of 
thyroid function through Tg gene transcription and Tg iodination 
[30, 48]. 
 The present literature review identified several categories of 
phytochemicals that may have an impact on thyroid physiology and 
disease, and  discussed their potential effects on the Nrf2 pathway. 
Reports that address the effects of specific phytochemicals on both 
the thyroid and the activity of Nrf2 are rather few; therefore, we 
also included studies using other tissues/cell lines to provide in-
sights into whether a certain phytochemical’s effects on the thyroid 
may be derived from its potential to modulate the Nrf2 pathway. 
Figure 1 briefly summarizes the potential effects of these com-
pounds on thyroid gland function and physiology. 
 In summary, there are phytochemicals with known antioxidant 
or other cytoprotective properties that have shown promising results 
in the field of cancer prevention, but may have a detrimental effect 
on thyroid function at certain doses or in certain combinations. 
Thus, caution should be exercised when drawing conclusions about 
the potential beneficial or detrimental effects of a phytochemical on 
thyroid function, and this issue should be carefully characterized, 
including via classical toxicology approaches. While the health 
benefits associated with natural compounds found in plants in low 
amounts are generally well accepted, attention should be drawn to 
potential toxicities arising from the use of concentrated extracts that 
may contain excess amounts of phytochemicals. For instance, a 
daily dose of 600 µmol glucoraphanin and 40 µmol sulforaphane in 
the form of broccoli sprout extracts over 12 weeks has been shown 
to be effective against the detoxification of airborne pollutants 
[234], and this dosing scheme was proven to be  safe for the thyroid 
[187]. 
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Table 4. Modulation of Nrf2 pathway and thyroid function by quinones and terpenoids. 
Compound Model system Impact on Nrf2 and/or effect on thyroid function/morphology 
1,5-Dicaffeoylquinic acid primary culture rat cortical astrocytes [188] mediates glutathione synthesis via Nrf2A, NP [188]  
18α- Glycyrrhetinic Acid 
HFL-1 human primary fibroblasts [189]; 
human neuroblastoma SH-SY5Y cells [190]; 
murine cortical neurons [190]; C. elegans 
[190] 
↑Nrf2, ↑ proteasome subunits [189]; ↑Nrf2, ↑ oxidative stress resistance 
[190]; ↑ cellular lifespan [190]; ↑ organismal lifespan [190] 
3-Caffeoyl, 4- dihydro-
caffeoyl quinic acid 
Hepa1c1c7 cells [191] scavenges ROS, regulates HO-1 via PI3K/Akt-Nrf2 PtW, HP [191]  
Andalusol 
Conchitriol 
Lagascatriol 
PC12 cells [192] Nrf2 PtWA, NP, AO [192] 
Antroquinonol B-cell-deficient M [193] Nrf2 PtWA, T cells and NLRP3I, NephP [193]  
Carnosic acid PC12 COS7 cells [194] Keap1/Nrf2 PtwA via cysteine S-alkylation, NP [194] 
Carnosol PC12 cells [195] ↑Nrf2, ↑HO-1 expression via PI3K/Akt PtwA, NP [195] 
Celastrol 
HaCaT cells [196]; 8505C and SW1736 cells 
[197] 
↑HO-1 expression via ROS/Nrf2/ARE signaling [196]; ↓cell viability, 
↑cytotoxic activity, AC [197] 
Emodin, Aloe emodin 
mouse primary microglia [198]; thyroid can-
cer cell line K1 [199] 
HO-1 and NQO1 induction via AMPK/Nrf2 signaling, AI, NP [198]; pro-
motes apoptosis of K1 cells [199]  
Kahweol SH-SY5Y cells [199] HO-1 regulation via the PI3K and p38/Nrf2 PtW, NP [199]  
Kaurenoic acid RAW264.7 and HEK293 cells [200] Nrf2A, AI [200] 
Linearol 
Sidol 
PC12 cells [201] ↓ROS production via Nrf2 antioxidant system modulation, NP, AO [201] 
Maslinic Acid HepG2 cells  [202] induces NOQ1 and HO-1 expression via Nrf2A, CyP [202] 
Mollugin HNSCC4 and HNSCC12 cells [203] HO-1 and Nrf2 PtW and NF-"B, CyP [203]  
Oridonin MDAMB-231 breast carcinoma cells [204] Nrf2A, CyP, protection against arsenic-induced toxicity [204] 
Plumbagin human neuroblastoma SH-SY5Y cells [205] Nrf2/ARE PtWA by PI3K-mediated mechanism, NP [205] 
Pseudolaric acid B SW579  [206] AC [206] 
Pulchellamin G murine peritoneal macrophages [207] ↑HO-1 expression via ↑Nrf2 nuclear translocation, AI [207] 
Tanshinone I 
human bronchial epithelium cells 16HBE14o  
[208] 
Nrf2A, CyP [208] 
Tanshinone IIA 
human aortic smooth muscle cells (HASMCs) 
[209] 
Nrf2A via ERK and PKB PtW-CyP, AO [209] 
Triptolide 
HL60 and K562 leukemia cell lines [210]; R 
[211]; Human ATC cells [212] 
HIF-1a and Nrf2, AC, enhances drug sensitivity[210]; Nrf2/HO-1 PtwA, 
CarP [211]; AC [212] 
Zerumbone, RL34 cells [213] ↑nuclear accumulation of Nrf2-ChP [213] 
α-iso-cubebenol human macrophage THP-1 cells [214] induces HO-1 expression via Nrf2, PI3K/Akt, and ERKA, AI [214] 
HO-1, heme oxygenase 1; NQO1, NAD(P)H quinone dehydrogenase 1; AMPK, 5' AMP-activated protein kinase; AI, anti-inflammatory; NP, neuroprotective; 
ROS, reactive oxygen species; ↑, increase; ↓, decrease; AC, anticancer; PI3K, phosphoinositide-3-kinase; Akt/PKB, protein kinase B; PtW, pathway; HP, hepa-
toprotective; ERK, extracellular signal-regulated kinase; CyP, cytoprotective; AO, antioxidative; , up-regulate; NF-kB, nuclear factor kappa-light-chain-
enhancer of activated B cells; NLRP3, the NLR family, pyrin domain-containing 3 inflammasome; I, inhibit; NephP, nephroprotective; HIF-1a, hypoxia-
inducible factor 1-alpha; CarP, cardioprotective; A, activate. 
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Table 5. Plant extracts with potential clinical utility and their respective effects on the thyroid gland. 
Extract Model System 
Impact on Thyroid Function/morphology; Potential 
Medical Use 
Aglaia coriacea, Aglaia gracilis, Aglaia elaeagnoidea, Aglaia 
edulis, Aglaia odorata, Stemona tuberosa, Aglaia basiphylla, 
Aglaia tenuicaulis, Stemona collinsae 
medullary thyroid carci-
noma cell lines 
AC [221] 
Aloe vera, Aegle marmelios leaf extracts M ↓T3 concentration, treatment of hyperthyroidism [219] 
Bacopa monnieri leaf extracts M ↑T4 concentration, treatment of hypothyroidism [219] 
Cassava, bamboo shoot, cauliflower, cabbage boiled extracts 
human thyroid 
tissues 
TPOI [217] 
Green and black tea extract R 
↓T3 and T4 serum levels and 5DI and TPOA, ↑Na+, K+-
ATPaseA, ↑TSH concentration [220] 
Kalanchoe brasiliensis aqueous extract 
human diffuse toxic goiter 
tissue 
TPOI [218] 
Lycopus americanus, Lycopus europaeus, Lycopus virginicus 
arious, Lithospermum officinale, Lithospermum ruderale ex-
tracts 
H treatment of hyperthyroidism [216] 
Plectranthus barbatus, Withania somnifera, Centella asiatica, 
Commiphora mukul extracts 
H treatment of hypothyroidism [216] 
H, human; I, inhibit; A, activate; ↑, increase; ↓, decrease; 5DI, type I 5'-deiodinase; AC, anticancer. 
 
Table 6. Other natural compounds with ability to modulate Nrf2 activity and potentially affect thyroid function. 
Compound Model system Impact on Nrf2 and effect 
3‐hydroxy‐β‐damascone Hepa 1c1c7 murine hepatoma cells Nrf2-dependent induction of phase 2 DMEs, AC [222] 
4-Ketopinoresinol HSC-3 cells Nrf2/HO-1A via PI3K/AKT signaling, CyP, AO [223] 
Ankaflavin MG-induced R Nrf2 phosphorylation, HO-1 and GCLA, AO, ADb [224] 
Eckol Chinese hamster lung fibroblast (V79-4) Nrf2-mediated HO-1 expression via ERK and PI3K/AKT PtW, CyP [225] 
Falcarindiol normal rat liver Clone 9 cells induction of phase 2 DMEs through Nrf2 PtW, CyP [226] 
Forsythiaside A BV2 microglia cells Nrf2/HO-1A PtW, Nrf2 and HO-1 expression, NF-kBI, AI [227] 
Fucoxanthin murine hepatic BNL CL.2 Cells 
↑HO-1 and NQO1 mRNA and protein expression via Nrf2/ARE PtWA, pro-
oxidant activity [228] 
Gymnasterkoreayne B HCT116 human colon cancer cells induces NQO-1 and Nrf2 translocation via  ERK and PKC PtW, ChP [229] 
Ochratoxin A porcine kidney tubule cells LLC-PK1 ↓GST and γGCS mRNA levels via Nrf2 PtW, nephrotoxicity [230] 
Sauchinone M Nrf2 and PKC-δ A, GSK3β phosphorylationI, CyP, HP [231] 
Schisandrin B H9c2 cells ERK/Nrf2A PtW, AO, CyP [232] 
Triphlorethol A Chinese hamster lung fibroblast (V79-4) HO-­‐1 gene expression via Nrf2 and ERKA, CyP, AO [233] 
HO-1, heme oxygenase 1; A, activate; PtW, pathway; , up-regulate; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; I, inhibit; AI, anti-
inflammatory; GST, glutathione S-transferase; γGCS, gamma glutamyl cysteine synthetase; ERK, extracellular signal-regulated kinase; AO, antioxidative; 
CyP, cytoprotective; PKC-­‐δ, protein kinase C delta; GSK3β, glycogen synthase kinase 3 beta; HP, hepatoprotective; DMEs, drug-metabolizing enzymes; PKC, 
protein kinase C; ChP, chemoprotective; MG, methylglyoxal; GCL, glutamate–cysteine ligase; ADb, antidiabetic; AC, anticancer; ↑, increase; NQO1, 
NAD(P)H quinone dehydrogenase 1. 
 
 To conclude, this review catalogues the phytochemicals that 
may have an effect on the thyroid gland and on the Nrf2 pathway, 
and it conveys the message that each dietary supplement intended 
for human use that contains such phytochemicals, should be care-
fully evaluated in this aspect, first by analyzing its contents, and 
then by assessing its potential effects on thyroid function. Such 
diligence will contribute to realizing the promise of the old yet 
highly active field of “chemoprevention” against diseases via natu-
ral compounds, aiming to propose novel treatments by identifying 
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new, cost-efficient and safe therapeutic agents to promote public 
health. 
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